Clinical Trials Logo

Glucose, High Blood clinical trials

View clinical trials related to Glucose, High Blood.

Filter by:

NCT ID: NCT05215210 Completed - Clinical trials for Impaired Glucose Tolerance

The Effect of Long-term Momordica Charantia Supplementation on Blood Glucose Levels

Bitter-Zoet 2
Start date: March 23, 2022
Phase: N/A
Study type: Interventional

The study is a parallel, double blind, controlled trial in which study participants will receive a 12-week intervention with 3.6 g/d dried bitter-gourd supplements or a reference intervention with 3.6 g/d dried cucumber supplements. Research subjects will come to the research facility for a test day on four occasions, with an interval of 4 weeks. The main study parameter is fasting levels of plasma glucose.

NCT ID: NCT05182190 Completed - Glucose, High Blood Clinical Trials

Effects of Black Bean Pasta Consumption on Biomarkers in Young Adults

Start date: July 10, 2019
Phase: N/A
Study type: Interventional

The study purpose is to determine the effect of eating three (3) different pasta flour formulations made from 100% black beans (Zenith) in a meal matrix (spaghetti sauce) on postprandial glycemic response in healthy adults.

NCT ID: NCT05159453 Not yet recruiting - Glucose, High Blood Clinical Trials

Dose Response Study of Transdermal Human Insulin in Patients

LEVPS
Start date: January 2, 2024
Phase: Phase 2/Phase 3
Study type: Interventional

A 21-Day open label study of transdermally delivered human insulin in Type 2 Diabetics as measured by response of down modulation of glucose after dosing of Insulin as compared to historic patient response to injected insulins.

NCT ID: NCT05071950 Completed - Glucose, High Blood Clinical Trials

The Effect of D-allulose on the Glycemic Changes in Patients With Type 2 Diabetes Mellitus During Ramadan Fasting

Start date: March 10, 2021
Phase: N/A
Study type: Interventional

Postprandial hyperglycemia or rapid rise in blood glucose is defined as a blood glucose level>7.8 mmol/L (140 mg/dL) 1- 2 hours after consumption of food. It is associated to the development of diabetes among healthy individuals and a risk factor for the onset and progression of microvascular and macrovascular complications among diabetic patients. In Ramadan, postprandial hyperglycemia is often observed after the iftar (fasting break after sunset). The frequency of eating normally decreases during Ramadan, however, the energy intake remains questionable because dietary practices during Ramadan are influenced by local culture, economic status and individual dietary behaviors. In many Muslim societies including Malaysia, Ramadan has known as a month of feasting. Iftar meals are typically high calorie, carbohydrate-rich and usually sweet food resulting in rapid rise in glucose after the meal. This poses a challenge for the people with diabetes to manage their glucose level. D-allulose (a C-3 epimer of D-fructose) is a rare sugar and reported to have several health benefits, such as suppressing a rise in postprandial glucose levels. There is still a scarcity of research on patients with diabetes. As a result, the current clinical study sought to investigate the effect of supplemental D-allulose on participants with type 2 diabetes who consume real-meal calories during Ramadan iftar.

NCT ID: NCT05056376 Active, not recruiting - Obesity Clinical Trials

Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this research study is to compare the effectiveness of a fully automated digital diabetes prevention program to standard of care human coach-based diabetes prevention programs for promoting clinically meaningful lifestyle changes to reduce the risk of type 2 diabetes in adults with prediabetes.

NCT ID: NCT04893148 Active, not recruiting - Clinical trials for Type 2 Diabetes Mellitus

Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes

Start date: May 26, 2020
Phase: Phase 4
Study type: Interventional

The investigators aimed to compare efficacy and safety of IGlarLixi and insulin glargine plus dulaglutide as intensification from basal insulin with metformin, in the absence of head-to-head trials.

NCT ID: NCT04846751 Enrolling by invitation - Glucose, High Blood Clinical Trials

Exercise Type That Faster Reduces Postprandial Glycemia.

GLYEXER
Start date: November 1, 2021
Phase: N/A
Study type: Interventional

It is well established that a bout of 50 min of continuous moderate intensity exercise, improves insulin sensitivity up to 48 hours after the bout. However, it is less well known, what is the exercise type more efficient to buffer the elevations in blood glucose elicited by carbohydrate ingestion. The purpose of this study is to elucidate if intervalic exercise is superior to continous on improving postprandial glycemic control.

NCT ID: NCT04648397 Completed - Glucose, High Blood Clinical Trials

The Effect of Chewing Duration on Blood Glucose Levels

Start date: November 16, 2020
Phase: N/A
Study type: Interventional

This study aims to assess the impact of speed of consumption of two starch-based foods varying in fibre content on blood glucose levels in normal healthy subjects. Furthermore, the mediating roles of salivary amylase and particle size on blood glucose levels will be studied. The study has a randomized cross-over design. Subjects consume two test-lunches (chick peas and brown rice) in duplicate on 8 different test days, at either long or short chewing duration. Glucose responses will be monitored via a continuous glucose monitoring device and expectorated boluses will be collected during each test day for assessments of amylase activity and food particle size.

NCT ID: NCT04641689 Active, not recruiting - Obesity Clinical Trials

Stand Up Kansas: An Intervention to Reduce Sedentary Behavior in the Home Work Environment

Start date: October 21, 2020
Phase: N/A
Study type: Interventional

This project will examine the effectiveness of an intervention to reduce sedentary behavior in Kansas State University employees who are primarily working from home. We will recruit 100 employees to participate. Participants will be randomly assigned to one of four conditions: desk only, program only, desk + program, or waitlist control. The program will consist of strategies to reduce sitting and increase physical activity in the home environment. We will assess whether the intervention successfully elicits reductions in sitting among employees, as well as changes in cardiometabolic and work-related outcomes.

NCT ID: NCT04632277 Completed - Diabetes Mellitus Clinical Trials

Is Mg do Improve the Glycemic Control in Patients Drink a Desalinate Water

Mg
Start date: August 25, 2020
Phase: N/A
Study type: Interventional

Background and aim: Diabetes mellitus as a chronic disease is on rise on parallel with diseases. Magnesium (Mg) supplementation may help control glycemic response among type 2 diabetes (T2D) patients. We aim to present an overview of the possible influence of drinking water in general and mineral water in particular in improving glycemic parameters in persons with type 2 diabetes. Method: A randomized double blind controlled clinical trial will be conducted at the Endocrine clinic (KFHU) on 900 of patients with T2DM. All subjects participated in this study will be randomly allotted into three groups (each group N=300) to which the three waters were supplied in similar bottles marked A "tap water", B "bottle water" and C "control without any intervention". Blood samples will be taken before and after the intervention to determine the serum concentration of magnesium, Calcium, Vit D, creatinine, FBS, serum Ca, HbA1c, fasting C-peptide levels, fasting insulin levels and insulin sensitivity. Magnesium and calcium levels in urine will be expressed as the creatinine ratio